These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13873504)

  • 1. Symposium on clinical drug evaluation and human pharmacology. V. An ametric approach to bioassay.
    BROSS ID
    Clin Pharmacol Ther; 1962; 3():369-73. PubMed ID: 13873504
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioassay of suspensions of the Nelson mouse ascites tumor treated with chemicals in vitro.
    TARNOWSKI GS; BATES LA
    Cancer Res; 1961 Sep; 21():377-534. PubMed ID: 13775345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to the study of a biological assay on plants for the evaluation of potential antineoplastic drugs. II. Variations in the composition of the terminal portions of the roots of Allium cepa L. subjected to the action of synthetic antineoplastic agents: thiotepa, chloramine, oxychlorine].
    GHELARDI-PRIMAVORI G
    Boll Chim Farm; 1961 Feb; 100():112-27. PubMed ID: 13704896
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical appraisal of the "human tumor stem-cell assay".
    Selby P; Buick RN; Tannock I
    N Engl J Med; 1983 Jan; 308(3):129-34. PubMed ID: 6336820
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative evaluation of drug influence on vital and metabolic processes of cell culture in suspensions].
    Karzel K; Breull W; Hack G
    Arzneimittelforschung; 1970 Dec; 20(12):1843-9. PubMed ID: 5537078
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug evaluation in experimental tumor systems: potential and limitations in 1961.
    SKIPPER HE
    Cancer Chemother Rep; 1962 Feb; 16():11-8. PubMed ID: 13913648
    [No Abstract]   [Full Text] [Related]  

  • 7. A manual on quantitative drug evaluation in experimental tumor systems.
    GOLDIN A; VENDITTI JM
    Cancer Chemother Rep; 1962 Apr; 17():145-78. PubMed ID: 13899780
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental evaluation of potential anticancer agents. IV. Host weight loss as it relates to false positives in drug evaluation.
    LASTER WR; SCHABEL FM; SKIPPER HE; WILCOX WS; THOMSON JR
    Cancer Res; 1961 Aug; 21():895-906. PubMed ID: 13759334
    [No Abstract]   [Full Text] [Related]  

  • 9. Method of biological assay of compounds effective in the treatment of IRC 741 leukemia in Fischer rats.
    ARMAGHAN V
    J Natl Cancer Inst; 1960 Jul; 25():125-31. PubMed ID: 13794263
    [No Abstract]   [Full Text] [Related]  

  • 10. GROWTH INHIBITION OF PHYSARUM POLYCEPHALUM FOR THE EVALUATION OF CHEMOTHERAPEUTIC AGENTS.
    BECKER J; DANIEL JW; RUSCH HP
    Can Res Suppl; 1963 Nov; ():1910-29. PubMed ID: 14080627
    [No Abstract]   [Full Text] [Related]  

  • 11. Symposium on clinical drug evaluation and human pharmacology. Introduction. Clinical pharmacology: a definition.
    MODELL W
    Clin Pharmacol Ther; 1962; 3():235-8. PubMed ID: 14474954
    [No Abstract]   [Full Text] [Related]  

  • 12. A manual on quantitative drug evaluation in experimental tumor systems. I. Background, description of criteria, and presentation of quantitative therapeutic data on various classes of drugs obtained in diverse experimental tumor systems.
    SKIPPER HE; SCHMIDT LH
    Cancer Chemother Rep; 1962 Apr; 17():1-143. PubMed ID: 13913647
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncology drug discovery applications using the FMAT 8100 HTS system.
    Lee JY; Miraglia S; Yan X; Swartzman E; Cornell-Kennon S; Mellentin-Michelotti J; Bruseo C; France DS
    J Biomol Screen; 2003 Feb; 8(1):81-8. PubMed ID: 12855001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of anticancer drugs.
    Oliverio VT
    Natl Cancer Inst Monogr; 1977 Mar; (45):57-61. PubMed ID: 927495
    [No Abstract]   [Full Text] [Related]  

  • 15. Symposium on clinical drug evaluation and human pharmacology. IV. Placebos: problems and pitfalls.
    WOLF S
    Clin Pharmacol Ther; 1962; 3():254-7. PubMed ID: 14007964
    [No Abstract]   [Full Text] [Related]  

  • 16. Fifth NCI-EORTC symposium on new drugs in cancer therapy. October 22-24, 1986, Amsterdam, The Netherlands. Abstracts.
    Invest New Drugs; 1987; 5(1):37-136. PubMed ID: 3507416
    [No Abstract]   [Full Text] [Related]  

  • 17. Fourth NCI-EORTC symposium on new drugs in cancer therapy. Brussels, Belgium, December 14-17, 1983. Abstracts.
    Invest New Drugs; 1984; 2(1):85-128. PubMed ID: 6469503
    [No Abstract]   [Full Text] [Related]  

  • 18. The place of pharmacology in cancer medicine.
    Capizzi RL
    Semin Oncol; 1977 Jun; 4(2):131-3. PubMed ID: 877598
    [No Abstract]   [Full Text] [Related]  

  • 19. Symposium on clinical drug evaluation and human pharmacology. X. Evaluation of antibacterial agents.
    LEPPER M
    Clin Pharmacol Ther; 1962; 3():392-6. PubMed ID: 14464193
    [No Abstract]   [Full Text] [Related]  

  • 20. Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
    Ishizaki T; Sugita M
    Clin Pharmacol Ther; 1974 Sep; 16(3):577-84. PubMed ID: 4415183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.